The synthesis of novel glucagon-like peptide-1 receptor agonists presents a unique set of circumstances for pharmaceutical scientists. Biopharmaceutical companies sometimes require targeted manufacturing capabilities https://tirzeptide.com/collections/fda-registered-peptides/products/bpc-158